Institut National De La Santé Et De La Recherche Médicale, France
Clinical trials sponsored by Institut National De La Santé Et De La Recherche Médicale, France, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Brain function in Friedreich's ataxia: new clues from genetic testing Results expected Sep 2026 (estimated)
- Can we predict who will suffer severe leptospirosis? Results expected Sep 2026 (estimated)
- Could a simple nerve block ease debilitating Post-Stroke pain? Results expected Sep 2026 (estimated)
- Concussion before age 6: what happens to a Child's brain? Results expected Oct 2026 (estimated)
- Brain scans and genetics may predict anorexia relapse Results expected Oct 2026 (estimated)
-
Kaposi's sarcoma drug trial halted early – what we know
Disease control Stopped earlyThis phase II trial tested the drug everolimus in 11 people with classic or endemic Kaposi's sarcoma, a rare skin cancer linked to a virus. The goal was to see if the drug could shrink tumors after 6 months. The study was terminated early, so the full results are not available.
Phase 2 • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Zap to talk: brain stimulation tried for aphasia after stroke
Symptom relief Stopped earlyThis study tested whether a gentle electrical current applied to the scalp (tDCS) during speech therapy could help stroke survivors with aphasia name objects better. Only 5 people took part, and the study was stopped early, so the results are not reliable enough to draw conclusio…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Symptom relief
Last updated Jun 26, 2026 13:31 UTC
-
Dyslexia study probes hidden link between movement and reading
Knowledge-focused Stopped earlyThis study looked at whether children with dyslexia have trouble sensing their own body movements (proprioception). Researchers compared 56 French children aged 10-12, half with dyslexia and half without, by testing how well they could detect motion and position. The goal was to …
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Scientists hunt for genetic and environmental clues in rare lung disease
Knowledge-focused Stopped earlyThis study aimed to describe the features and natural history of idiopathic interstitial pneumopathy, a group of rare lung diseases, in both children and adults. Researchers planned to collect data from 1,600 participants, including medical history, imaging, and genetic tests, to…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
App aims to improve tracking of rare paralysis attacks
Knowledge-focused Stopped earlyThis study tested a smartphone app designed to help people with periodic paralysis record their muscle weakness episodes in real time. The goal was to see if the app could collect more accurate information about attacks compared to standard interviews during doctor visits. Only 2…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC